Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000910662-07-000296
Filing Date
2007-06-18
Accepted
2007-06-18 17:22:05
Documents
4
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 FY 2006 form20fa1.txt 20-F/A 8669
2 SECTION 302(A) CERTIFICATION OF CEO ex12_1.txt EX-12.1 3794
3 SECTION 302(A) CERTIFICATION OF CFO ex12_2.txt EX-12.2 3780
4 CONSENT OF KPMG ex15_1.txt EX-15.1 1012
  Complete submission text file 0000910662-07-000296.txt   18735
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-22320 | Film No.: 07926585
SIC: 2835 In Vitro & In Vivo Diagnostic Substances